Thromboprophylaxis after renal transplantation and patient risk stratification: The case of mTOR inhibitors

Luis Jara-Palomares, Aurora Solier-López, Mariaconcetta Russo, Marta Suñer, Francisco González-Roncero, Hessel Peters-Sengers, Saskia Middeldorp, Frederike J. Bemelman, Stefano Barco

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)100-102
Number of pages3
JournalThrombosis Research
Volume195
DOIs
Publication statusPublished - Nov 2020

Keywords

  • Everolimus
  • mTORi
  • Renal transplant
  • Sirolimus
  • Venous thromboembolism

ASJC Scopus subject areas

  • Hematology

Cite this

Jara-Palomares, L., Solier-López, A., Russo, M., Suñer, M., González-Roncero, F., Peters-Sengers, H., Middeldorp, S., Bemelman, F. J., & Barco, S. (2020). Thromboprophylaxis after renal transplantation and patient risk stratification: The case of mTOR inhibitors. Thrombosis Research, 195, 100-102. https://doi.org/10.1016/j.thromres.2020.07.018